Dr. Reddy's Laboratories

Dr. Reddy’s Expands Access to Immunotherapy for Rare Head and Neck Cancer

JOHANNESBURG, South Africa / HYDERABAD, India, Aug. 3, 2026 Dr. Reddy’s Laboratories South Africa announced the registration of an...

By cGxPwire Editor
August 5, 2026

Bio-Pharma

Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar

HYDERABAD, India, Aug. 1, 2026 Dr. Reddy’s Laboratories Ltd. announced that the U.S. Food and Drug Administration (FDA) has...

By cGxPwire Editor
August 5, 2026

Pharma

Innoviva and Dr. Reddy’s Expand Global Access to XACDURO®

WALTHAM, Mass., June 16, 2026 Innoviva Specialty Therapeutics announced an exclusive distribution and licensing agreement with Dr. Reddy’s Laboratories...

By cGxPwire Editor
June 17, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Dr. Reddy’s Laboratories

Dr. Reddy’s Expands Access to Immunotherapy for Rare Head and Neck Cancer

Dr. Reddy’s Laboratories Secures U.S. FDA Approval for Rituximab Biosimilar

Innoviva and Dr. Reddy’s Expand Global Access to XACDURO®